Integrated Proteins Ltd.

As of June 30, 2026, Integrated Proteins Ltd. carries a market capitalization of 2.84B, placing it among publicly traded companies globally. Its enterprise value stands at 2.84B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

As of June 30, 2026, Integrated Proteins Ltd. has 190.84M shares outstanding.

As of June 30, 2026, Integrated Proteins Ltd. trades at a trailing price-to-earnings ratio of 447.95.

As of June 30, 2026, Integrated Proteins Ltd. trades at an EV/EBITDA multiple of 369.91 - the valuation measure that neutralizes differences in capital structure, tax rates, and depreciation policy, making it the standard yardstick for comparing companies across an industry. The EV/Sales ratio of 13.88 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. Its EV/EBIT multiple of 369.91 values the business against core operating earnings after depreciation, a stricter test than EV/EBITDA for capital-intensive businesses. These enterprise value multiples are built on an enterprise value of 2.84B versus a market cap of 2.84B, with the gap driven by net debt and cash on the balance sheet.

These figures are as of June 30, 2026.

Over the twelve months ended June 30, 2026, Integrated Proteins Ltd. recorded 1.39M in income tax expense. That works out to an effective tax rate of 18.08, which can sit above or below the statutory corporate tax rate depending on foreign earnings mix, tax credits, and one-off items. Taxes are levied on pretax income of 7.68M, leaving 6.29M in net income after tax - the gap is what shifts in the tax rate do to reported earnings and EPS.

As of the close on October 22, 2026, Integrated Proteins Ltd.'s stock has gained approximately 320.00% over the past 52 weeks. The 50-day moving average sits at 13.81, while the 200-day moving average is 10.37.

Over the twelve months ended June 30, 2026, Integrated Proteins Ltd. generated 204.36M in revenue and converted that into 6.29M in net income, yielding earnings per share of 0.03. EBITDA reached 7.67M, while operating income came in at 7.67M.

Over the twelve months ended June 30, 2026, Integrated Proteins Ltd. posted a gross margin of 4.66, reflecting its pricing power and cost economics. The operating margin of 3.75 and net profit margin of 3.08 provide insight into operational efficiency.

Integrated Proteins Ltd.'s most recent stock split took place on September 4, 2026 with a 1:10 split ratio.